Search market news

GE HealthCare Reports Results for Quarter Ended September 30

GE HealthCare Reports Results for Quarter Ended September 30

GE HealthCare Technologies Inc. reported results for the quarter ended September 30. The supplied text contains no results figures.

HCA Healthcare Reports Results for Quarter Ended September 30

Customers Bancorp Reports Q3 EPS of $2.25, Up 10%

Customers Bancorp reported third-quarter EPS of $2.25, up 10% quarter over quarter, with deposits rising 11% year over year to a record $22.6 billion and loans up 14% to a record $18.5 billion. The bank set 2026 guidance for loan growth of 12% or higher and deposit growth of 9% or more.

Molina Healthcare Reports Results for Quarter Ended September 30

Molina Healthcare reported results for the quarter ended September 30. The supplied body contains no financial figures.

Healthcare Services Group Reports Quarterly Results

Healthcare Services Group reported results for the quarter ended September 30. The supplied summary contains no financial figures.

Thermo Fisher Raises 2026 Revenue and Adjusted EPS Guidance

Thermo Fisher reported Q3 revenue of $12.14 billion, up 9%, and adjusted EPS of $6.68, up 15%. It raised 2026 revenue guidance to $47.7–$48.2 billion and adjusted EPS guidance to $25.13–$25.43.

Atlantic Union Bankshares Reports Q3 2026 Results and Loan Growth

Atlantic Union Bankshares reported third-quarter results, including average loans up 9.6% annualized to period-end loans of $29.3 billion and average deposits up 1.5% annualized to $31 billion. Net interest margin fell 6 basis points to 3.88%, while net interest income rose $3.4 million; the company also lowered full-y

Genuine Parts Reports Q3 Sales Growth, Narrows 2026 EPS Guidance

Genuine Parts reported third-quarter 2026 sales of $6.5 billion, up 4% year over year, and adjusted EPS of $2.07, up approximately 5%. The company narrowed its 2026 adjusted EPS guidance to $7.50–$7.75 and said its planned separation into two standalone public companies remains on track for Q1 2027.

ManpowerGroup Reports Q3 Revenue of $4.8 Billion, Names Next CEO

ManpowerGroup reported third-quarter revenue of $4.8 billion, with organic constant-currency growth of 6%. Becky Frankiewicz will become CEO effective January 1, 2027, as Jonas Prising becomes Executive Chair; fourth-quarter revenue growth is forecast at 3% to 7%.

Wipro Announces Results for the Quarter Ended September 30, 2026

For best results when printing this announcement, please click on link below: Wipro Announces Results for the Quarter Ended September 30, 2026 IT services segment revenue flat sequentially and increased 0.6% YoY CC Operating Margin at 16.5% expanded 0.5% QoQ EPS increased 4.2% YoY; Operating cash flow at 165.8% of Net

Auna Reports Preliminary Key Performance Indicators for the Third Quarter ended September 30, 2026

For best results when printing this announcement, please click on link below: Auna Reports Preliminary Key Performance Indicators for the Third Quarter ended September 30, 2026 Auna S.A. (“Auna” or the “Company”), a leading healthcare services platform in Latin America with operations in Mexico, Peru, and Colombia, tod

TRADING DAY — Earnings season debuts to mixed reviews

By Stephen Culp NEW YORK, Oct 13 (Reuters) — Wall Street stocks were muted on Tuesday after big banks reported mixed earnings and investors looked ahead to Wednesday's crucial inflation report. The S&P 500 ended essentially flat, while Nasdaq closed slightly lower, weighed by chip weakness. Third-quarter earnings optim

IMPLANET Reports Revenue of €10.6 Million for the First Nine Months of 2026, up 21%

For best results when printing this announcement, please click on link below: IMPLANET Reports Revenue of €10.6 Million for the First Nine Months of 2026, up 21% Q3 2026 revenue up 18% to €3.44 million Ninth consecutive quarter of sustained growth U.S. revenue up 32% in Q3 2026 and 45% over the first nine months of 202

UnitedHealth Group Incorporated reports results for the quarter ended September 30 — Earnings Summary

UnitedHealth Group Incorporated reported quarterly adjusted earnings of $4.69​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $2.92. The mean expectation of twenty five analysts for the quarter was for earnings of $4.14 per share. Wall Street expe

Johnson & Johnson reports Q3 2026 results, raises 2026 guidance

For best results when printing this announcement, please click on link below: Johnson & Johnson reports Q3 2026 results, raises 2026 guidance 2026 Third-Quarter reported sales growth of 5.9% to $25.4 Billion with operational growth of 6.0%* and adjusted operational growth of 6.1% 2026 Third-Quarter earnings per share (

UnitedHealth Group Reports Third Quarter 2026 Results

For best results when printing this announcement, please click on link below: UnitedHealth Group Reports Third Quarter 2026 Results Third Quarter 2026 Revenues of $112.7 Billion; Earnings from Operations of $6.6 Billion Earnings of $4.56 Per Share and Adjusted Earnings of $4.69 Per Share Cash Flows from Operations Were

Arlo Reports Record Q2 Revenue, Raises 2026 Guidance

Arlo reported Q2 revenue of $156 million, up more than 20% year over year, and non-GAAP EPS of $0.28, up 65%. It raised full-year 2026 revenue and EPS guidance.

Weave Communications Q2 2026 Earnings Call: Complete Transcript

Weave Communications (NYSE: WEAV ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. Access the full call at Summary Weave Communications repor

Transcript: Omada Health Q2 2026 Earnings Conference Call

Omada Health (NASDAQ: OMDA ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit Access the full call at Summary Omada Health reported its stro

Scholar Rock Holding Reports Q2 2026 Results: Full Earnings Call Transcript

Scholar Rock Holding (NASDAQ: SRRK ) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. View the webcast at Summary Scholar Rock Holdin

Amylyx Pharma Q2 2026 Earnings Call Transcript

Amylyx Pharma (NASDAQ: AMLX ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at Summary Amylyx Pharma re

Warby Parker Reports Q2 2026 Results: Full Earnings Call Transcript

Warby Parker (NYSE: WRBY ) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary Warby Parker Inc. reported Q2 2026 revenue of

Collegium Pharmaceutical Reports Q2 2026 Results: Full Earnings Call Transcript

Collegium Pharmaceutical (NASDAQ: COLL ) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered APIs. For comprehensive financial data and transcripts, visit The full earnings call is available at Summary Collegium Pharmaceutical re

Jabil Reports Q4 2026 Results: Full Earnings Call Transcript

On Wednesday, Jabil (NYSE: JBL ) discussed fourth-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary Jabil Inc reported a strong finish to fiscal 2026 with Q4 revenue

Redx Pharma announces final audited results for 15-month period ended Dec. 31, 2025

Redx Pharma reported audited results for the 15-month period ended Dec. 31, 2025, after changing its financial year-end. The company also said it expects its Skye Bioscience transaction and financing, with aggregate gross proceeds of up to $125 million, to close in Q4 2026.

Beacon Rise Holdings publishes half-year financial report

The company said it published unaudited condensed interim financial statements for the six months ended 30 June 2026. It also said the report was submitted to the UK Listing Authority and will be available on its website and the National Storage Mechanism.

Legence Reports Q2 2026 Results: Full Earnings Call Transcript

On Thursday, Legence (NASDAQ: LGN ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary Legence reported Q2 2026 revenue of $1.3 billion, a 111% incre

Transcript: Biofrontera Q2 2026 Earnings Conference Call

On Thursday, Biofrontera (NASDAQ: BFRI ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit Access the full call at Summary Biofrontera Inc. reported a 33% increase in net produ

Incannex Healthcare Inc reports results for the quarter ended June 30 - Earnings Summary

FORECAST CHANGESRECOMMENDATIONSThis summary was machine generated from LSEG data September 28 at 12:37 p.m. UTC. ​All figures in Australian dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, co…